142 related articles for article (PubMed ID: 25875278)
1. Images in clinical medicine. Loss of fingerprints.
Chavarri-Guerra Y; Soto-Perez-de-Celis E
N Engl J Med; 2015 Apr; 372(16):e22. PubMed ID: 25875278
[No Abstract] [Full Text] [Related]
2. [Breast cancer and the hand-foot syndrome].
Llambrich C; Falcou MC; De Rycke Y; Cottu P; Carrié S; Medjbari M
Soins; 2012 Jun; (766):25-8. PubMed ID: 22870762
[TBL] [Abstract][Full Text] [Related]
3. Unilateral hand-foot syndrome: does it take sides? Case report and literature review.
Almeida da Cruz L; Hoff PM; Ferrari CL; Riechelmann RS
Clin Colorectal Cancer; 2012 Mar; 11(1):82-4. PubMed ID: 21764392
[No Abstract] [Full Text] [Related]
4. [Capecitabine-induced hyperpigmentation followed by hand-foot syndrome: a new case report].
Agharbi FZ; Meziane M; Benhemmne H; Daoudi K; Elmesbahi O; Mikou O; Mernissi FZ
Ann Dermatol Venereol; 2012 Mar; 139(3):221-2. PubMed ID: 22401689
[No Abstract] [Full Text] [Related]
5. Travel warning with capecitabine.
Wong M; Choo SP; Tan EH
Ann Oncol; 2009 Jul; 20(7):1281. PubMed ID: 19470576
[No Abstract] [Full Text] [Related]
6. [Hand-foot syndrome induced by chemotherapy: a case study].
Simão DA; Lima ED; Souza RS; Faria TV; Azevedo GF
Rev Bras Enferm; 2012; 65(2):374-8. PubMed ID: 22911424
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of AboundTM for hand-foot syndrome caused by capecitabine].
Fujii C; Imamura H; Fukunaga M; Kamigaki S; Kimura Y; Kawase T; Kawabata R; Fujino M; Iseki C; Hamaguchi Y; Yamamoto E; Ishizaka T; Hachino Y
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2457-9. PubMed ID: 24394143
[TBL] [Abstract][Full Text] [Related]
8. [Assessment of hand-foot syndrome in cancer patients treated with capecitabine-containing chemotherapy].
Yamagiwa K; Shigematsu T; Takeda K; Shirai M; Amemori K; Sunda K; Koike C; Yamada T
Gan To Kagaku Ryoho; 2013 Dec; 40 Suppl 2():161-3. PubMed ID: 24712132
[TBL] [Abstract][Full Text] [Related]
9. Capecitabine-induced hand-foot syndrome complicated by pseudomonal superinfection resulting in bacterial sepsis and death: case report and review of the literature.
Hoesly FJ; Baker SG; Gunawardane ND; Cotliar JA
Arch Dermatol; 2011 Dec; 147(12):1418-23. PubMed ID: 22184763
[TBL] [Abstract][Full Text] [Related]
10. [A woman with palmar and plantar hyperpigmentation].
van Tienhoven G; Wilmink JW
Ned Tijdschr Geneeskd; 2011; 155(45):A4100. PubMed ID: 22085578
[TBL] [Abstract][Full Text] [Related]
11. Subacute cutaneous lupus erythematosus after treatment with capecitabine.
Kindem S; Llombart B; Requena C; Ruiz A; Traves V; Guillen C; San Martin O
J Dermatol; 2013 Jan; 40(1):75-6. PubMed ID: 22937906
[No Abstract] [Full Text] [Related]
12. Loss of Fingerprints as a Side Effect of Capecitabine Therapy: Case Report and Literature Review.
Zhao J; Zhang X; Cui X; Wang D; Zhang B; Ban L
Oncol Res; 2020 Feb; 28(1):103-106. PubMed ID: 31558182
[TBL] [Abstract][Full Text] [Related]
13. Lichenoid photosensitive eruption due to capecitabine chemotherapy for metastatic breast cancer.
Hague JS; Ilchyshyn A
Clin Exp Dermatol; 2007 Jan; 32(1):102-3. PubMed ID: 16879449
[No Abstract] [Full Text] [Related]
14. Elementary, my dear Watson.
García-Saénz JA; Martín M; Díaz-Rubio E
J Clin Oncol; 2007 May; 25(13):1815-6. PubMed ID: 17470879
[No Abstract] [Full Text] [Related]
15. Pooled analysis of individual patient data from capecitabine monotherapy clinical trials in locally advanced or metastatic breast cancer.
Blum JL; Barrios CH; Feldman N; Verma S; McKenna EF; Lee LF; Scotto N; Gralow J
Breast Cancer Res Treat; 2012 Dec; 136(3):777-88. PubMed ID: 23104222
[TBL] [Abstract][Full Text] [Related]
16. Granulomatous septal panniculitis associated with capecitabine (Xeloda).
Dalmau J; Roé E; Puig L; Alomar A
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):121-2. PubMed ID: 18181993
[No Abstract] [Full Text] [Related]
17. A case of capecitabine-induced hyperpigmentation and radiation recall phenomenon.
Ghosal N; Misra V
Clin Oncol (R Coll Radiol); 2009 Oct; 21(8):632. PubMed ID: 19304468
[No Abstract] [Full Text] [Related]
18. Capecitabine induced inflammation of actinic keratoses.
Krathen M; Treat J; James WD
Dermatol Online J; 2007 Oct; 13(4):13. PubMed ID: 18319010
[TBL] [Abstract][Full Text] [Related]
19. Capecitabine-related cardiotoxicity: recognition and management.
Saif MW; Tomita M; Ledbetter L; Diasio RB
J Support Oncol; 2008 Jan; 6(1):41-8. PubMed ID: 18257400
[No Abstract] [Full Text] [Related]
20. Chemotherapy and fingerprint loss: beyond cosmetic.
Al-Ahwal MS
Oncologist; 2012; 17(2):291-3. PubMed ID: 22298801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]